HUE037718T2 - Virális vektor elõállítása - Google Patents

Virális vektor elõállítása

Info

Publication number
HUE037718T2
HUE037718T2 HUE14858802A HUE14858802A HUE037718T2 HU E037718 T2 HUE037718 T2 HU E037718T2 HU E14858802 A HUE14858802 A HU E14858802A HU E14858802 A HUE14858802 A HU E14858802A HU E037718 T2 HUE037718 T2 HU E037718T2
Authority
HU
Hungary
Prior art keywords
production
virtual vector
virtual
vector
Prior art date
Application number
HUE14858802A
Other languages
English (en)
Hungarian (hu)
Inventor
Paul Michael Howley
Liang Liu
Original Assignee
Sementis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013904242A external-priority patent/AU2013904242A0/en
Application filed by Sementis Ltd filed Critical Sementis Ltd
Publication of HUE037718T2 publication Critical patent/HUE037718T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151Methods of production or purification of viral material
    • C12N2710/24152Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HUE14858802A 2013-11-01 2014-11-03 Virális vektor elõállítása HUE037718T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013904242A AU2013904242A0 (en) 2013-11-01 Viral vector manufacture
AU2014900370A AU2014900370A0 (en) 2014-02-07 Orthopox vectors and propagation

Publications (1)

Publication Number Publication Date
HUE037718T2 true HUE037718T2 (hu) 2018-09-28

Family

ID=53003022

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14858802A HUE037718T2 (hu) 2013-11-01 2014-11-03 Virális vektor elõállítása

Country Status (24)

Country Link
US (2) US10544397B2 (enExample)
EP (2) EP3375882B1 (enExample)
JP (2) JP6682443B2 (enExample)
KR (1) KR102047030B1 (enExample)
CN (1) CN106255758B (enExample)
AU (1) AU2014344738B2 (enExample)
CA (1) CA2931518C (enExample)
CY (1) CY1121414T1 (enExample)
DK (2) DK3063278T3 (enExample)
ES (1) ES2670034T3 (enExample)
HR (1) HRP20180789T1 (enExample)
HU (1) HUE037718T2 (enExample)
LT (1) LT3063278T (enExample)
NO (1) NO3063278T3 (enExample)
NZ (1) NZ720241A (enExample)
PL (1) PL3063278T3 (enExample)
PT (1) PT3063278T (enExample)
RS (1) RS57290B1 (enExample)
RU (1) RU2658487C2 (enExample)
SG (1) SG11201603919XA (enExample)
SI (1) SI3063278T1 (enExample)
SM (1) SMT201800267T1 (enExample)
TR (1) TR201807128T4 (enExample)
WO (1) WO2015061858A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI728173B (zh) * 2016-08-19 2021-05-21 澳大利亞商賽門堤斯有限公司 病毒疫苗
JP2018081568A (ja) * 2016-11-17 2018-05-24 グローリー株式会社 紙幣収納装置および紙幣処理機
CA3258751A1 (en) * 2022-06-30 2024-01-04 Bavarian Nordic As Mammalian cell line for the production of modified Ankara vaccine virus (MVA)
EP4590841A2 (en) * 2022-09-20 2025-07-30 Aldevron, LLC Best1 vectors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604183B1 (fr) * 1986-09-23 1988-12-30 Transgene Sa Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
EP0758397B1 (en) * 1994-04-29 2005-06-22 Baxter Healthcare S.A. Recombinant poxviruses with foreign polynucleotides in essential regions
DE60336653D1 (de) * 2002-08-07 2011-05-19 Bavarian Nordic As Vaccinia virus wirtspektrum gene zur erhöhung des titers von avipoxviren
FR2884255B1 (fr) * 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
AU2007280004A1 (en) * 2006-08-04 2008-02-07 Dublin City University A method of producing recombinant biological products

Also Published As

Publication number Publication date
SG11201603919XA (en) 2016-07-28
CY1121414T1 (el) 2020-05-29
CN106255758B (zh) 2020-06-23
JP2016534755A (ja) 2016-11-10
RU2658487C2 (ru) 2018-06-21
TR201807128T4 (tr) 2018-06-21
EP3063278A4 (en) 2017-04-12
CA2931518A1 (en) 2015-05-07
CN106255758A (zh) 2016-12-21
AU2014344738B2 (en) 2019-03-21
WO2015061858A1 (en) 2015-05-07
CA2931518C (en) 2021-03-09
EP3375882A1 (en) 2018-09-19
PT3063278T (pt) 2018-05-25
NZ720241A (en) 2019-10-25
EP3375882B1 (en) 2019-10-16
DK3375882T3 (da) 2019-12-16
US20200190482A1 (en) 2020-06-18
RS57290B1 (sr) 2018-08-31
EP3063278A1 (en) 2016-09-07
DK3063278T3 (en) 2018-06-06
SMT201800267T1 (it) 2018-07-17
US20170029784A1 (en) 2017-02-02
RU2016121425A (ru) 2017-12-04
EP3063278B1 (en) 2018-02-28
AU2014344738A1 (en) 2016-06-09
PL3063278T3 (pl) 2018-08-31
KR20160079868A (ko) 2016-07-06
JP2020039340A (ja) 2020-03-19
ES2670034T3 (es) 2018-05-29
KR102047030B1 (ko) 2019-11-20
HK1223395A1 (en) 2017-07-28
SI3063278T1 (sl) 2019-04-30
NO3063278T3 (enExample) 2018-07-28
LT3063278T (lt) 2018-07-10
US10544397B2 (en) 2020-01-28
HRP20180789T1 (hr) 2018-09-07
JP6682443B2 (ja) 2020-04-15

Similar Documents

Publication Publication Date Title
GB2517212B (en) A Computer Generated Emulation of a subject
EP4170633C0 (en) GALLBLADDER MODEL
LT3470690T (lt) Surinktas produktas
DK3015467T3 (da) Morpholino-oligonukleotidfremstillingsfremgangsmåde
GB201314084D0 (en) Production of graphene
PL2809157T3 (pl) Pirazolowe mieszaniny grzybobójcze
TWD174480S (zh) 耳機之部分
DK2986722T3 (da) Manipulerede phenylalaninammoniak-lyasepolypeptider
GB201517764D0 (en) Simulation of production systems
TWD174479S (zh) 耳機之部分
LT3060577T (lt) Rekombinantinio lubricino gamyba
DK2943561T3 (da) Fotobioreaktor
GB2512302B (en) Animation of a virtual object
EP2964517A4 (en) ROWING
GB201310432D0 (en) Virus Production
EP2961900A4 (en) FRAGILE FASTENING ELEMENT
DK2968528T3 (da) Immunmodulation
HUE037718T2 (hu) Virális vektor elõállítása
GB201305361D0 (en) Enhanced expression
EP2994114C0 (en) Separable capsule
IL228655A0 (en) New dolls
FR3009167B1 (fr) Casque
IL227280A (en) Reduction of rocket jet stream dispersion
TWM475834U (en) Improved structure of glove
FR3001469B1 (fr) Perfectionnement a une dame manuelle